CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 63 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14 | -22.2% | 10,548 | 0.0% | 0.01% | -25.0% |
| Q2 2023 | $18 | +157.1% | 10,548 | +132.7% | 0.01% | +166.7% |
| Q1 2023 | $7 | -100.0% | 4,533 | -77.3% | 0.00% | -78.6% |
| Q3 2022 | $29,000 | -21.6% | 20,000 | 0.0% | 0.01% | -17.6% |
| Q2 2022 | $37,000 | +362.5% | 20,000 | +566.7% | 0.02% | +466.7% |
| Q1 2022 | $8,000 | -33.3% | 3,000 | +115.8% | 0.00% | -40.0% |
| Q2 2020 | $12,000 | +9.1% | 1,390 | 0.0% | 0.01% | -16.7% |
| Q1 2020 | $11,000 | +37.5% | 1,390 | +42.3% | 0.01% | +100.0% |
| Q4 2019 | $8,000 | +100.0% | 977 | +81.9% | 0.00% | +50.0% |
| Q3 2019 | $4,000 | 0.0% | 537 | +48.3% | 0.00% | 0.0% |
| Q2 2019 | $4,000 | 0.0% | 362 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $4,000 | -20.0% | 362 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $5,000 | – | 362 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,576,471 | $36,526,000 | 1.44% |
| Altium Capital Management LP | 273,703 | $1,793,000 | 0.67% |
| Jackson Creek Investment Advisors LLC | 80,367 | $526,000 | 0.21% |
| HARBOURVEST PARTNERS LLC | 79,193 | $519,000 | 0.20% |
| XTX MARKETS LLC | 14,169 | $93,000 | 0.19% |
| Perceptive Advisors | 2,577,043 | $16,880,000 | 0.18% |
| RTW INVESTMENTS, LP | 1,527,352 | $10,004,000 | 0.17% |
| Exane Asset Management | 30,568 | $200,220,000 | 0.14% |
| Virtus ETF Advisers LLC | 37,343 | $245,000 | 0.10% |
| Congress Park Capital LLC | 25,807 | $169,000 | 0.10% |